Tissue plasminogen activator for thrombolytic therapy: expectation versus reality.

about

Tissue plasminogen activator for thrombolytic therapy: expectation versus reality.

Item

http://www.wikidata.org/entity/Q55314224

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年学术文章

@wuu

1992年学术文章

@zh-cn

1992年学术文章

@zh-hans

1992年学术文章

@zh-my

1992年学术文章

@zh-sg

1992年學術文章

@yue

1992年學術文章

@zh

1992年學術文章

@zh-hant

name

Tissue plasminogen activator for thrombolytic therapy: expectation versus reality.

@en

Tissue plasminogen activator for thrombolytic therapy: expectation versus reality.

@nl

type

Item

label

Tissue plasminogen activator for thrombolytic therapy: expectation versus reality.

@en

Tissue plasminogen activator for thrombolytic therapy: expectation versus reality.

@nl

prefLabel

Tissue plasminogen activator for thrombolytic therapy: expectation versus reality.

@en

Tissue plasminogen activator for thrombolytic therapy: expectation versus reality.

@nl

P1476

Tissue plasminogen activator for thrombolytic therapy: expectation versus reality.

@en

P2093

Gaffney PJ

http://www.w3.org/2001/XMLSchema#string

P2860

Roles for chloride ion and fibrinogen in the activation of [Glu1]plasminogen in human plasma

Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.

Basic and clinical aspects of fibrinolysis and thrombolysis.

Tissue-type plasminogen activator. Mechanisms of action and thrombolytic properties.

Thrombolytic therapy: current status (2).

Fibrin subunits in venous and arterial thromboembolism.

Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.

Mutant and chimeric recombinant plasminogen activators. Production in eukaryotic cells and preliminary characterization.

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

Characterization of a fusion protein consisting of amino acids 1 to 263 of tissue-type plasminogen activator and amino acids 144 to 411 of urokinase-type plasminogen activator.

P304

692-698

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1992-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1474556

http://www.w3.org/2001/XMLSchema#string

P921

thrombolysis

P932

1293730

http://www.w3.org/2001/XMLSchema#string